Clinical Trial Update: A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating long-term safety and tolerability of MK-0653C in Japanese participants with hypercholesterolemia; completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heterozygous Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• MK-0653C

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2018-01-11